オープン アクセスを義務付けられた論文 - Stuart Pitson詳細
一般には非公開: 16 件
Recent advances in the development of sphingosine kinase inhibitors
MR Pitman, M Costabile, SM Pitson
Cellular signalling 28 (9), 1349-1363, 2016
委任: National Health and Medical Research Council, Australia
Molecular targets of FTY720 (fingolimod)
MR Pitman, JM Woodcock, AF Lopez, SM Pitson
Current molecular medicine 12 (10), 1207-1219, 2012
委任: National Health and Medical Research Council, Australia
ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism
ST Boyle, V Poltavets, J Kular, NT Pyne, JJ Sandow, AC Lewis, ...
Nature Cell Biology 22 (7), 882-895, 2020
委任: Australian Research Council, National Health and Medical Research Council …
From sphingosine kinase to dihydroceramide desaturase: a structure–activity relationship (SAR) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl …
L Aurelio, CV Scullino, MR Pitman, A Sexton, V Oliver, L Davies, ...
Journal of medicinal chemistry 59 (3), 965-984, 2016
委任: National Health and Medical Research Council, Australia
Sphingosine kinase 1 in viral infections
JM Carr, S Mahalingam, CS Bonder, SM Pitson
Reviews in medical virology 23 (2), 73-84, 2013
委任: Australian Research Council, National Health and Medical Research Council …
Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b
KG Lim, F Tonelli, E Berdyshev, I Gorshkova, T Leclercq, SM Pitson, ...
The international journal of biochemistry & cell biology 44 (9), 1457-1464, 2012
委任: National Health and Medical Research Council, Australia
Post-translational regulation of sphingosine kinases
H Chan, SM Pitson
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2013
委任: National Health and Medical Research Council, Australia
Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses
JK Calvert, KJ Helbig, D Dimasi, M Cockshell, MR Beard, SM Pitson, ...
Journal of Interferon & Cytokine Research 35 (8), 654-665, 2015
委任: National Health and Medical Research Council, Australia
Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1
DH Pham, JA Powell, BL Gliddon, PAB Moretti, A Tsykin, M Van der Hoek, ...
Oncogene 33 (48), 5559-5568, 2014
委任: National Health and Medical Research Council, Australia
CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1
W Zhu, KE Jarman, NA Lokman, HA Neubauer, LT Davies, BL Gliddon, ...
Cancer research 77 (18), 4823-4834, 2017
委任: National Health and Medical Research Council, Australia
Sphingolipids and the unfolded protein response
MK Bennett, CT Wallington-Beddoe, SM Pitson
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2019
委任: National Health and Medical Research Council, Australia
In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection
WH Al-Shujairi, JN Clarke, LT Davies, MR Pitman, JK Calvert, AL Aloia, ...
Journal of General Virology 100 (4), 629-641, 2019
委任: National Health and Medical Research Council, Australia
Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1
JA Powell, MR Pitman, JR Zebol, PAB Moretti, HA Neubauer, LT Davies, ...
Biochemical Journal 476 (21), 3211-3226, 2019
委任: US National Institutes of Health, National Health and Medical Research …
Sphingolipids as multifaceted mediators in ovarian cancer
MR Pitman, MK Oehler, SM Pitson
Cellular Signalling 81, 109949, 2021
委任: National Health and Medical Research Council, Australia
The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate
F Savira, AR Kompa, DJ Kelly, R Magaye, X Xiong, L Huang, D Liew, ...
Vascular Pharmacology 141, 106923, 2021
委任: National Health and Medical Research Council, Australia
Mechanisms Driving Resistance to Proteasome Inhibitors Bortezomib, Carfilzomib, and Ixazomib in Multiple Myeloma
MK Bennett, SM Pitson, CT Wallington-Beddoe
Resistance to Targeted Therapies in Multiple Myeloma, 39-59, 2021
委任: National Health and Medical Research Council, Australia
一般公開: 84 件
The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity
V Poltavets, M Kochetkova, SM Pitson, MS Samuel
Frontiers in oncology 8, 431, 2018
委任: National Health and Medical Research Council, Australia
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen …
F Tonelli, KG Lim, C Loveridge, J Long, SM Pitson, G Tigyi, R Bittman, ...
Cellular signalling 22 (10), 1536-1542, 2010
委任: US National Institutes of Health, British Heart Foundation, Cancer Research UK
Roles, regulation and inhibitors of sphingosine kinase 2
HA Neubauer, SM Pitson
The FEBS journal 280 (21), 5317-5336, 2013
委任: National Health and Medical Research Council, Australia
Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet–fed mice
CR Bruce, S Risis, JR Babb, C Yang, GM Kowalski, A Selathurai, ...
Diabetes 61 (12), 3148-3155, 2012
委任: National Health and Medical Research Council, Australia
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます